Do drug firm ties affect researchers’ reporting of study results?
Charles Piller
Academic scientists who ignore legal requirements to publicly report clinical trial results often have received large payments from drug companies involved in the studies, a STAT review of federal data found. John Abramson (HMS) is quoted.